Caregiver Burden in Caregivers of Patients With Multiple Sclerosis
Summary
A new observational clinical study (NCT07549048) registered on ClinicalTrials.gov will evaluate caregiver burden in individuals aged 18-80 years who are caring for patients with clinically diagnosed multiple sclerosis. The study will assess caregiver insomnia using the Insomnia Severity Index, anxiety and depression using the Hospital Anxiety and Depression Scale, and caregiver burden using the Zarit Caregiver Burden Scale. Patient disease characteristics including duration, ambulation status, and functional disability will be measured using the Expanded Disability Status Scale and Multiple Sclerosis Impact Scale. No interventions are planned; the study is purely observational.
“Caregiver burden will be assessed using the Zarit Caregiver Burden Scale.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This document registers a new observational clinical study on ClinicalTrials.gov. The study will recruit individuals with multiple sclerosis and their caregivers to assess caregiver burden, insomnia, anxiety, and depression using validated instruments including the Zarit Caregiver Burden Scale, Insomnia Severity Index, and Hospital Anxiety and Depression Scale. Participating patients will have their disease characteristics and functional status evaluated using the Expanded Disability Status Scale and Multiple Sclerosis Impact Scale.
Affected parties include patients with multiple sclerosis and their caregivers who may be eligible for enrollment, as well as healthcare providers and researchers in neurology and rehabilitation medicine who may wish to refer patients or follow study developments. The study produces no regulatory obligations and has no compliance implications for healthcare institutions.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Caregiver Burden in Caregivers of Patients With Multiple Sclerosis
Observational NCT07549048 Kind: OBSERVATIONAL Apr 23, 2026
Abstract
Individuals aged 18-80 years who have been clinically diagnosed with multiple sclerosis and their caregivers will be included in the study.
Demographic data of the patients, including age, height, weight, and comorbidities, will be recorded. Disease-specific characteristics such as disease duration, presence of incontinence, ambulation status, and presence and severity of pain will be assessed. Functional status of the patients will be evaluated using the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Impact Scale (MSIS). Symptoms related to depression and anxiety in patients will be assessed using the Hospital Anxiety and Depression Scale (HADS).
Subsequently, caregivers of the patients will be evaluated. The severity of insomnia will be assessed using the Insomnia Severity Index (ISI). Symptoms related to anxiety and depression will be evaluated using the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be assessed using the Zarit Caregiver Burden Scale.
Conditions: Multiple Sclerosis
Interventions: No intervention
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.